Author

Nikki L. Ross

Observed names: Nikki L Ross, Nikki Ross, Ross, Nikki Lea

Observed institutions: Moffitt Cancer Center, Spark Therapeutics (United States), Cambridge College, University of Delaware

OpenAlex ID: A5089692938

A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties

2021 · Kevin Dooley, Russell E. McConnell, et al. · Molecular Therapy · 307

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance

2021 · Su Chul Jang, Kyriakos D. Economides, et al. · Communications Biology · 162

Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood

2022 · Corinne J. Smith, Nikki Ross, et al. · Frontiers in Immunology · 85

Histone-targeted Polyplexes Avoid Endosomal Escape and Enter the Nucleus During Postmitotic Redistribution of ER Membranes

2015 · Nikki L Ross, Erik V Munsell, et al. · Molecular Therapy — Nucleic Acids · 45

Requirements for the nuclear entry of polyplexes and nanoparticles during mitosis

2012 · John D. Larsen, Nikki L. Ross, et al. · The Journal of Gene Medicine · 37

Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus

2016 · Erik V. Munsell, Nikki L. Ross, et al. · Current Pharmaceutical Design · 32

Overexpression of caveolin‐1 in inflammatory breast cancer cells enables IBC‐specific gene delivery and prodrug conversion using histone‐targeted polyplexes

2016 · Nikki L. Ross, Millicent O. Sullivan · Biotechnology and Bioengineering · 20

Abstract 944: exoSTING: An engineered exosome therapeutic that selectively delivers STING agonist to the tumor resident antigen-presenting cells resulting in improved tumor antigen-specific adaptive immune response

2019 · Su Chul Jang, Raymond J. Moniz, et al. · Cancer Research · 12

Importin-4 Regulates Gene Delivery by Enhancing Nuclear Retention and Chromatin Deposition by Polyplexes

2015 · Nikki L. Ross, Millicent O. Sullivan · Molecular Pharmaceutics · 11

Abstract 944: exoSTING: An engineered exosome therapeutic that selectively delivers STING agonist to the tumor resident antigen-presenting cells resulting in improved tumor antigen-specific adaptive immune response

2019 · Su Chul Jang, Raymond J. Moniz, et al. · Immunology · 3

490. Histone-Targeted Polyplexes Avoid Endosomal Escape and Enter the Nucleus During Post-Mitotic Redistribution of ER Membranes

2015 · Nikki L. Ross, Millicent O. Sullivan · Molecular Therapy · 2

Fluorescent dye incorporation causes weakened gene association and intracellular aggregate formation in nonviral carriers

2015 · Abbygail A. Foster, Nikki L. Ross, et al. · The Journal of Gene Medicine · 2

703 Engineered exosomes with altered cellular tropism achieve targeted STING agonist delivery and single-agent tumor control in vivo

2020 · Monique Kauke, Nikki Ross, et al. · Regular and Young Investigator Award Abstracts · 1

Improving non-viral gene delivery with histone-targeted polyplexes: uptake, trafficking, and nuclear deposition

2024 · Ross, Nikki Lea · Library, Museums and Press - UDSpace (University of Delaware)

Ninth Australasian Gene and Cell Therapy Society Meeting

2015 · Abbygail A. Foster, Nikki L. Ross, et al. · The Journal of Gene Medicine

Histone-mimetic polyplexes for targeted intracellular delivery during gene transfer

2014 · Nikki Ross, Millicent O. Sullivan · Northeast Bioengineering Conference

The role of oxidative stress on tau protein homeostasis in neurodegenerative diseases

2012 · Nikki L. Ross · Library, Museums and Press - UDSpace (University of Delaware)

Availability and affordability of colorectal cancer screening and diagnostic services within a patient navigator research program

2007 · Desiree Rivers, Alicia Bahadur, et al. · Cancer Epidemiology and Prevention Biomarkers

Works count: 18

Citation count: 719

H-index: 9

I10-index: 9